Brain tumor patients happier when paramedics train with simulations?
NCT ID NCT06962215
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether training paramedics with simulations can make brain tumor patients more satisfied with their care. About 250 adults with a newly discovered brain tumor will fill out a questionnaire after their hospital stay. The goal is to see if this training helps patients feel better supported.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 250 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
May 2025
- Expected to finish
-
Oct 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patient over 18 years of age * Patient covered by a social security scheme * Patient signed informed consent form * Patient found to have a brain tumor (potentially malignant, primary or secondary if this is the mode of entry into the disease) * Hospitalization in the Neurosurgery Department at the time of tumor discovery, before the histological diagnosis is announced. Exclusion Criteria: * Patients with a personal history of cancer * Patient without family AND unable to receive information
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Brain tumor are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
11 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
APHM Nord
NOT_YET_RECRUITINGMarseille, 13000, France
-
CHU Amiens
NOT_YET_RECRUITINGAmiens, 80000, France
-
CHU Angers
NOT_YET_RECRUITINGAngers, 49100, France
-
CHU Bordeaux
NOT_YET_RECRUITINGBordeaux, 33000, France
-
CHU Brest
NOT_YET_RECRUITINGBrest, Brittany Region, 29200, France
-
CHU Nantes
NOT_YET_RECRUITINGNantes, 44000, France
-
CHU Nice
NOT_YET_RECRUITINGNice, 06000, France
-
CHU Rouen
NOT_YET_RECRUITINGRouen, 76000, France
-
CHU Saint Etienne
RECRUITINGSaint-Etienne, 42270, France
-
CHU Strasbourg
NOT_YET_RECRUITINGStrasbourg, 67000, France
-
CHU Tours
NOT_YET_RECRUITINGTours, 37000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- One extra radiation dose after standard brain cancer therapy: can it boost the immune system?
- Zapping the brain to restore lost vision
- Brain surgery delirium: can real-time monitoring protect older patients?
- Music as medicine: could ukulele lessons rebuild young brains after cancer?
- Can trained immune cells outsmart brain tumors?
- Digital tests may offer a new way to track brain health in tumor patients